Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Meeting Cancer Survivorship Needs in Hematological Malignancies Compared to Solid Malignancies: Experiences of a Primary Care-Based Survivorship Clinic

Ellen Zhang, Natasha Steele, Maya Ramachandran, Ilana Yurkiewicz

Blood (2024) 144 (Supplement 1): 3650.

https://doi.org/10.1182/blood-2024-200624

Published: 2024

Journal Articles

Long-Term Safety and Effectiveness of Pomalidomide for Bleeding in Hereditary Hemorrhagic Telangiectasia

Ellen Zhang, Pamela G Hodges, Josanna Rodriguez-Lopez, Hanny Al-Samkari

Blood (2024) 144 (Supplement 1): 558.

https://doi.org/10.1182/blood-2024-202284

Published: 2024

Journal Articles

Longitudinal Systemic Bevacizumab Therapy Produces Cost Savings and Improves Quality-Adjusted Life Expectancy in the Care of Patients with Hereditary Hemorrhagic Telangiectasia with Moderate-to-Severe Bleeding

Daniel Wang, Satoko Ito, Christina Waldron, Ayesha Butt, Ellen Zhang, Harlan M. Krumholz, Hanny Al-Samkari, George Goshua

Blood (2023) 142 (Supplement 1): 2312.

https://doi.org/10.1182/blood-2023-185340

Published: 2023

Journal Articles

Hereditary Hemorrhagic Telangiectasia May be the Most Clinically Significant and Morbid Inherited Bleeding Disorder of Women

Ellen Zhang, Zain Virk, Josanna Rodriguez-Lopez, Hanny Al-Samkari

Blood (2023) 142 (Supplement 1): 28.

https://doi.org/10.1182/blood-2023-187772

Published: 2023

Journal Articles

A Multicenter Study of Safety, Tolerability, and Effectiveness of Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia

Zain M Virk, Ellen Zhang, Josanna Rodriguez-Lopez, Alison Witkin, Alexandra Wong, Jay Luther, Angela Lin, Mingming Ning, Eric F. Grabowski, Eric Holbrook, Hanny Al-Samkari

Blood (2022) 140 (Supplement 1): 1418–1419.

https://doi.org/10.1182/blood-2022-164655

Published: 2022

NARROW

Meeting Cancer Survivorship Needs in Hematological Malignancies Compared to Solid Malignancies: Experiences of a Primary Care-Based Survivorship Clinic

Long-Term Safety and Effectiveness of Pomalidomide for Bleeding in Hereditary Hemorrhagic Telangiectasia

Longitudinal Systemic Bevacizumab Therapy Produces Cost Savings and Improves Quality-Adjusted Life Expectancy in the Care of Patients with Hereditary Hemorrhagic Telangiectasia with Moderate-to-Severe Bleeding

Hereditary Hemorrhagic Telangiectasia May be the Most Clinically Significant and Morbid Inherited Bleeding Disorder of Women

A Multicenter Study of Safety, Tolerability, and Effectiveness of Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia

Email alerts

ASH Publications

American Society of Hematology

Meeting Cancer Survivorship Needs in Hematological Malignancies Compared to Solid Malignancies: Experiences of a Primary Care-Based Survivorship Clinic

Long-Term Safety and Effectiveness of Pomalidomide for Bleeding in Hereditary Hemorrhagic Telangiectasia

Longitudinal Systemic Bevacizumab Therapy Produces Cost Savings and Improves Quality-Adjusted Life Expectancy in the Care of Patients with Hereditary Hemorrhagic Telangiectasia with Moderate-to-Severe Bleeding

Hereditary Hemorrhagic Telangiectasia May be the Most Clinically Significant and Morbid Inherited Bleeding Disorder of Women

A Multicenter Study of Safety, Tolerability, and Effectiveness of Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only